DUBLIN--(BUSINESS WIRE)--The "Global Bone Marrow Transplant Market 2019-2027" report has been added to ResearchAndMarkets.com's offering.
The global bone marrow transplant market is expected to progress with a CAGR of 5.13% during the years 2019-2027.
The market is driven by the increasing prevalence of blood tumors and anemia, extending bone marrow transplant registries and rising survival rate after treatment.
Also, the advancements in technology, rising per capita medicinal expenditures and improvements in healthcare infrastructure are additionally fueling the development of the bone marrow transplant market worldwide.
Conversely, deficiency of bone marrow contributors, uncertainty over repayment and the high cost of treatment are the reasons anticipated to hamper the demand for the global bone marrow transplant market.
Regional Outlook
The regions studied in the global bone marrow transplant market are the Middle East and Africa, North America, Latin America, Asia-Pacific, and Europe.
Europe is leading the bone marrow transplant market globally because of extending bone marrow registries and high density of bone marrow transplant centers.
Latin America is expected to witness a fast rise in terms of volume in the bone marrow transplant market, owing to the high number of potential candidates for the procedure.
North America is predicted to support the bone marrow transplant advertise in the district due to the expanding number of bone marrow transplant groups.
In the Asia-Pacific region, the bone marrow market is expected to witness a boost, despite the prevalence of meagerness of donors and the high cost of the system.
Key Topics Covered
1. Global Bone Marrow Transplant Market - Summary
2. Industry Outlook
2.1. Market Definition
2.2. Porters Five Forces Outlook
2.2.1. Threat of New Entrants
2.2.2. Threat of Substitutes
2.2.3. Bargaining Power of Buyers
2.2.4. Bargaining Power of Suppliers
2.2.5. Threat of Rivalry
2.3. Vendor Scorecard
2.4. Key Buying Criteria
2.5. Market Trends
2.6. Key Insights
2.7. Market Attractiveness Matrix
2.8. Market Drivers
2.8.1. Prevalence of Cancer Has Increased Worldwide
2.8.2. Increase in Federal Funding Offerings
2.9. Market Restraints
2.9.1. Imbalance in the Supply & Demand For Bone Marrow Transplant
2.9.2. Ethical Issues
2.10. Market Opportunities
2.10.1. Technological Inventions
2.10.2. Reimbursement Opportunities in Developed Nations
2.11. Market Challenges
2.11.1. High Cost of Treatment
3. Bone Marrow Transplant Industry Outlook - By Transplant Type
3.1. Autologous Bone Marrow Transplant
3.2. Allogeneic Bone Marrow Transplant
4. Bone Marrow Transplant Industry Outlook - By Indication
4.1. Multiple Myeloma
4.2. Acute Leukemia
4.3. Hodgkin Lymphoma
4.4. Non-Hodgkin Lymphoma
4.5. Solid Tumors
4.6. Other Indication
5. Bone Marrow Transplant Industry Outlook - By End-User
5.1. Multispecialty Clinics
5.2. Hospitals
5.3. Ambulatory Surgical Centers
6. Bone Marrow Transplant Industry - Regional Outlook
6.1. North America
6.1.1. Country Analysis
6.1.1.1. United States
6.1.1.2. Canada
6.2. Europe
6.3. Asia-Pacific
6.4. Latin America
6.5. Middle East and Africa (MEA)
7. Competitive Landscape
7.1. Abbott Laboratories
7.2. Affymetrix Inc. (Acquired by Thermofisher)
7.3. Agendia N.V.
7.4. Agilent Technologies Inc.
7.5. Ambrilia Biopharma Inc.
7.6. Astellas Pharma Inc.
7.7. Diadexus Inc. (Acquired by Diazyme Laboratories)
7.8. Illumina Inc.
7.9. Qiagen N.V.
7.10. Roche Diagnostics Ltd
7.11. Sanofi
7.12. Stryker Corporation
For more information about this report visit https://www.researchandmarkets.com/r/85h6vu
